🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mary C. Collins

Dana-Farber Cancer Institute

ORCID: 0000-0003-4282-9020

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies”.

A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies

Blood Advances(2024)10.1182/bloodadvances.2024014633

N/A

0.420DataRank · unranked

9 citations

Danielle M. Brander, Yesid Alvarado, Catherine Diefenbach, Daniel Nathan Egan, Shira Dinner +14 more

Hypomethylating agent decitabine sensitizes diffuse large B-cell lymphoma to venetoclax

Haematologica(2023)10.3324/haematol.2023.283245

N/A

0.406DataRank · unranked

14 citations

Jennifer L. Crombie, Wei Ni, Nguyet-Minh Hoang, Swati Garg, Liam Hackett +6 more

Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies

Journal of Clinical Investigation(2023)10.1172/jci170169

N/A

0DataRank · unranked

43 citations

Fen Zhu, Olga Dashevsky, Rin Mizuno, Jolin Xiao Hui Lai, Liam Hackett +19 more